Science Explorer Back to mapMap
Discussion
Researcher · Universidade Federal do Rio Grande do Sul · Brazil

David Driemeier

David Driemeier publishes mostly in Molecular Biology, Epidemiology and Small Animals, on topics such as Microbial infections and disease research, Plant Toxicity and Pharmacological Properties and Veterinary Oncology Research.

ORCID 0000-0003-3766-0654 OpenAlex
World rank
#7,665,974
of 7,710,434 ranked researchers
Rank in Brazil
#251,079
of 253,246
Works
828
Citations
7.3k
Citations per work
8.8
h-index
36
i10-index 252Top 9.6% in Molecular Biology
David Driemeier

What does David Driemeier research?

David Driemeier's work is mostly in Medicine (18%), Biochemistry, Genetics and Molecular Biology (8%), Veterinary (7%).

Everything else: 515 works · 62.2% of their workHealth Sciences: 207 works · 25.0% of their workMedicine: 148 works · 17.9% of their workEpidemiology: 61 works · 7.4% of their workInfectious Diseases: 46 works · 5.5% of their workPulmonary and Respiratory Medicine: 41 works · 5.0% of their workVeterinary: 59 works · 7.1% of their workSmall Animals: 59 works · 7.1% of their workLife Sciences: 106 works · 12.8% of their workBiochemistry, Genetics and Molecular Biology: 65 works · 7.8% of their workMolecular Biology: 65 works · 7.8% of their workImmunology and Microbiology: 41 works · 5.0% of their workParasitology: 41 works · 5.0% of their workTHEIR WORKDavid Driemeier828works
Life Sciences13%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else51562.2%
    1. Medicine14817.9%
    2. Veterinary597.1%
    1. Biochemistry, Genetics and Molecular Biology657.8%
    2. Immunology and Microbiology415.0%
  1. 1Molecular Biology8% of their works
  2. 2Epidemiology7% of their works
  3. 3Small Animals7% of their works
  4. 4Infectious Diseases6% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Parasitology5% of their works

Research topics

Which keywords describe David Driemeier's research?

The keywords of their largest research topics: Immunotherapy, Epidemiology, Genomic Sequencing, Pathogenesis, Mycoplasma, Pasteurella, Pyrrolizidine Alkaloids and Toxicity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Immunotherapy1883 topics
  2. Epidemiology1563 topics
  3. Genomic Sequencing1532 topics
  4. Pathogenesis1092 topics
  5. Mycoplasma941 topic
  6. Pasteurella941 topic
  7. Pyrrolizidine Alkaloids871 topic
  8. Toxicity871 topic
  9. Canine Cancer811 topic
  10. Comparative Oncology811 topic
  11. Oomycetes601 topic
  12. Retroviruses601 topic
  13. Coronavirus591 topic
  14. Gene Therapy591 topic
  15. Porcine Reproductive and Respiratory Syndrome Virus591 topic
  16. Viral Vectors591 topic
  17. Bluetongue Virus501 topic
  18. Culicoides Biting Midges501 topic
  19. HTLV-1471 topic
  20. Infection471 topic

Where does David Driemeier work?

David Driemeier's main affiliation in the publication record is Universidade Federal do Rio Grande do Sul, Brazil.

How many publications and citations does David Driemeier have?

OpenAlex counts 828 works and 7,292 citations for David Driemeier, an h-index of 36, ranking #7,665,974 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named David Driemeier

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Driemeier. Posts are plain text and can be reported.